RH officer Sandra Jean Moore-Pilon holds 783 shares
Some options were vested and exercisable on the reported date; others vest on stated future dates subject to continuous service.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
RH officer Sandra Jean Moore-Pilon, Chief Customer Experience & Values Officer, reported direct holdings of 783 common shares and seven stock-option positions tied to RH common stock. The listed options include 8,000 underlying shares at a $151.35 exercise price, expiring June 22, 2028, and 40,000 underlying shares at a $166.08 exercise price, expiring July 22, 2036. Several awards vest over time subject to continuous service.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Moore-Pilon Sandra Jean
Role
SEE REMARKS
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F4 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F5 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F6 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F7 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 96,000 contracts (Direct);
Common Stock — 783 shares (Direct)
Footnotes (7)
- F1. This option award is fully vested and exercisable.
- F2. This option award is vested and exercisable with respect to 6,400 of the shares and will vest and become exercisable with respect to an additional 1,600 shares on April 29, 2027, subject to continuous service.
- F3. This option award is vested and exercisable with respect to 1,500 of the shares and will vest and become exercisable with respect to an additional 750 shares on June 9, 2027, an additional 750 shares on June 9, 2028, an additional 1,000 shares on June 9, 2029, and an additional 1,000 shares on June 9, 2030, subject to continuous service.
- F4. This option award is vested and exercisable with respect to 1,000 of the shares and will vest and become exercisable with respect to an additional 500 shares on April 11, 2027, an additional 750 shares on April 11, 2028, an additional 750 shares on April 11, 2029, an additional 1,000 shares on April 11, 2030, and an additional 1,000 shares on April 11, 2031, subject to continuous service.
- F5. This option award is vested and exercisable with respect to 1,429 of the shares and will vest and become exercisable with respect to an additional 1,428 shares on April 13, 2027, an additional 1,429 shares on April 13, 2028, an additional 1,428 shares on April 13, 2029, an additional 1,429 shares on April 13, 2030, an additional 1,428 shares on April 13, 2031, and an additional 1,429 shares on April 13, 2032, subject to continuous service.
- F6. This option award will vest and become exercisable with respect to 2,000 shares on April 14, 2027, an additional 2,000 shares on April 14, 2028, an additional 2,000 shares on April 14, 2029, an additonal 3,000 shares on April 14, 2030, an additional 3,000 shares on April 14, 2031, and additional 4,000 shares on April 14, 2032, and an additional 4,000 shares on April 14, 2033, subject to continuous service.
- F7. This option award will vest and become exercisable with respect to 5,715 shares on July 23, 2027, an additional 5,715 shares on July 23, 2028, an additional 5,714 shares on July 23, 2029, an additonal 5,714 shares on July 23, 2030, an additional 5,714 shares on July 23, 2031, and additional 5,714 shares on July 23, 2032, and an additional 5,714 shares on July 23, 2033, subject to continuous service.
Key Figures
Direct common shares: 783 shares
Underlying shares under stock options: 8,000 shares
Underlying shares under stock options: 8,000 shares
+5 more
8 metrics
Direct common shares
783 shares
Sandra Jean Moore-Pilon's reported direct holding
Underlying shares under stock options
8,000 shares
Exercise price $151.35 per share; expiration June 22, 2028
Underlying shares under stock options
8,000 shares
Exercise price $154.82 per share; expiration April 28, 2030
Underlying shares under stock options
5,000 shares
Exercise price $264.27 per share; expiration June 8, 2033
Underlying shares under stock options
5,000 shares
Exercise price $267.09 per share; expiration April 10, 2034
Underlying shares under stock options
10,000 shares
Exercise price $164.62 per share; expiration April 12, 2035
Underlying shares under stock options
20,000 shares
Exercise price $130.72 per share; expiration April 13, 2036
Underlying shares under stock options
40,000 shares
Exercise price $166.08 per share; expiration July 22, 2036
Key Terms
Stock Option (Right to Buy), vested and exercisable, continuous service
3 terms
Stock Option (Right to Buy) technical
"Stock Option (Right to Buy)"
vested and exercisable technical
"vested and exercisable with respect to 6,400 of the shares"
continuous service technical
"subject to continuous service"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the exercise prices of Sandra Jean Moore-Pilon's RH stock options?
The seven reported options have exercise prices of $130.72, $151.35, $154.82, $164.62, $166.08, $264.27, and $267.09 per share. They relate to RH common stock.
When do Sandra Jean Moore-Pilon's RH options vest?
Some awards are fully vested and exercisable, while others have future vesting subject to continuous service. For example, an additional 1,600 shares under one award are scheduled to vest April 29, 2027; another award has 2,000-share vesting installments beginning April 14, 2027, and continuing through April 14, 2029.
AI-generated analysis. How Rhea-AI works. Not financial advice.
